Pephexia Therapeutics
PrivateLast Round
Grant
Jul 1, 2024
Total Funding Raised
$7.16M
Company Overview
Pephexia Therapeutics is a biotechnology company that focuses on the discovery and development of innovative peptide-based therapeutics for the treatment of cachexia, sarcopenia, and related metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pephexia Therapeutics Comparables
Compare Pephexia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Actimed Therapeutics | 80% | |
| Kalohexis | 78% | |
| Endevica Bio | 77% | |
Pephexia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Grant | Feb 7, 2024 | ||||
| Grant | Dec 1, 2023 | ||||
| Grant | Mar 9, 2022 | ||||
| VC Round | Dec 1, 2021 | ||||
Accelerator | Sep 23, 2021 |
Key People
Founding team and executive leadership
Pephexia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Eurostars SME programme | Grant |
| The Export and Investment Fund of Denmark | VC Round |
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 560% MoM, from 341 to 2.3K.
- Dec 9, 2025
Monthly visitors increased 84% MoM, reaching 1.3K.
Pephexia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pephexia Therapeutics's valuation, stock price, and market status.